The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease
Open accessAbstract
INTRODUCTION: Inflammatory processes are suspected in the pathomechanism of Alzheimer's dementia (AD) but the serum and cerebrospinal fluid (CSF) levels of inflammatory cytokines are not yet determined in the different forms of the disorder. SUBJECTS AND METHODS: Interleukin-6 (IL-6) levels were examined in the sera and CSF of patients with mild-moderate and severe stage of late onset sporadic type of AD and in the sera of demented Down syndrome (DS) probands with similar stages of AD and compared with data of age-matched healthy controls. RESULTS: Normal serum IL-6 levels were found in the mild-moderate stage, but significantly increased levels were found in the severe stage of both dementia groups. The CSF concentrations remained within the normal range in all groups. Positive correlations between the serum IL-6 levels and age and the severity of the disease were present. CONCLUSION: These findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052 · cited 1×
“Alzheimer's dementia (AD) is a genetically heterogenous neurodegenerative disorder where different mutations of presenilin (1-3) and amyloid precursor protein (APP) genes are reported (4,5).”
BackgroundAmyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Interleukin‐6 and α‐2‐macroglobulin indicate an acute‐phase state in Alzheimer's disease cortices
Bauer, J., Strauss, S., Schreiter-Gasser, U., Ganter, U., Schlegel, P., Witt, I., Yolk, B., & Berger, M. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80737-n · Cited by 483
Activation of the classical complement pathway in brain tissue of Alzheimer patients
McGeer, P. L., Akiyama, H., Itagaki, S., & McGeer, E. G. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90843-4 · Cited by 383
May, P. C., Lampert-Etchells, M., Johnson, S. A., Poirier, J., Masters, J. N., & Finch, C. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90342-d · Cited by 339
IL-2 and IL-6 secretion in dementia: correlation with type and severity of disease
Huberman, M., Sredni, B., Stern, L., Kott, E., & Shalit, F. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00016-u · Cited by 62
Research works printed but not linked: 25
- Levy, 1990, Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
- Wisniewski, 1985, Discrepancy between Alzheimer-type neuropathology and dementia in persons with Down's syndrome, Ann NY Acad Sci, 477, 247, 10.1111/j.1749-6632.1986.tb40344.x · DOI
- Cork, 1990, Neuropathology of Down syndrome and Alzheimer disease, Am J Med Genet, 7, 282
- Berkenbosch, 1993, Cytokines and inflammatory proteins in Alzheimer's disease, Res Immunol, 143, 657, 10.1016/0923-2494(92)80052-M · DOI
- Licastro, 1995, Acute phase reactant alfa-1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease, Alzheimer Dis Assoc Disord, 2, 112, 10.1097/00002093-199509020-00009 · DOI
- Akiyama, 1991, Immunohistochemical localization of vitronectin, its receptor and beta-3 integrin in Alzheimer brain tissue, J Neuro-immunol, 32, 19
- Satoh, 1988, Induction of neuronal differentation in PC12 cells by B-cell stimulatory factor 2/ interleukin 6, Mol Cell Biol, 8, 3546, 10.1128/MCB.8.8.3546 · DOI · Paper page
- Campbell, 1993, Neurologic disease induced in transgenic mice by cerebral over-expression of interleukin-6, Proc Natl Acad Sci USA, 90, 10061, 10.1073/pnas.90.21.10061 · DOI · Paper page
- Bo, 1995, Reciprocal control of inflammatory cytokines, IL-1, and IL-6, and beta-amyloid production in cultures, Neurosci Lett, 188, 70, 10.1016/0304-3940(95)11384-9 · DOI · Paper page
- Brugg, 1995, Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain, Proc Natl Acad Sci USA, 92, 3032, 10.1073/pnas.92.7.3032 · DOI · Paper page
- Vries, 1996, The influence of cytokines on the integrity of the blood-brain barrier in vitro, J Neuroimmunol, 64, 37, 10.1016/0165-5728(95)00148-4 · DOI · Paper page
- Schapiro, 1987, Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome, J Neurol Neurosurg Psychiatry, 50, 766, 10.1136/jnnp.50.6.766 · DOI
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- American Psychiatric Association (APA), 1987, Diagnostic and Statistical Manual of Mental Disorders
- Folstein, 1975, Mini-mental state. A practical method for grading the cognitive state of patients for the clinician, J Psychiat Res, 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
- Duijn, 1990, Serum levels of interleukin-6 are not elevated in patients with Alzheimer's disease, Neurosci Lett, 108, 350, 10.1016/0304-3940(90)90666-W · DOI
- Yamada, 1995, Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer's-type of dementia, Neurosci Lett, 186, 219, 10.1016/0304-3940(95)11318-Q · DOI
- Huberman, 1994, Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage, J Neuroimmunol, 52, 147, 10.1016/0165-5728(94)90108-2 · DOI
- Vandenabeele, 1991, IS amyloidogenesis during Alzheimer's disease due to an IL-1/IL-6-mediated “acute phase response” in the brain, Immunol Today, 217, 217, 10.1016/0167-5699(91)90032-O · DOI · Paper page
- Abraham, 1992, The role of acute-phase proteins alfa-l-antichymotrypsin in brain dysfunction and injury, Res Immunol, 143, 631, 10.1016/0923-2494(92)80047-O · DOI
- Erschler, 1993, Interleukin-6: a cytokine for gerontologist, J Am Geratr Soc, 41, 176, 10.1111/j.1532-5415.1993.tb02054.x · DOI · Paper page
- Pirtilla, 1994, Alfa-1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease, Neurobiol Aging, 15, 313, 10.1016/0197-4580(94)90026-4 · DOI
- Lawlor, 1996, Acute phase reactants in Alzheimer's disease, Biol Psychiatry, 39, 1051, 10.1016/0006-3223(95)00426-2 · DOI
- McRae, 1992, Immune responses in brains of Alzheimer's and Parkinson's disease patients: hypothesis and reality, Rev Neurosci, 3, 79, 10.1515/REVNEURO.1992.3.2.79 · DOI
- Perlmutter, 1990, Microangiopathy, the vascular basement membrane and Alzheimer's disease: a review, Brain Res Bull, 24, 677, 10.1016/0361-9230(90)90007-M · DOI · Paper page
Cited by
Immune modulation of learning, memory, neural plasticity and neurogenesis
Yirmiya, R., & Goshen, I. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.015 · Cited by 1,483
Inflammatory Proteins in Plasma and the Risk of Dementia: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Meijer, J., Kiliaan, A., Ruitenberg, A., van Swieten, J. C., Stijnen, T., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2004) · Archives of Neurology · doi:10.1001/archneur.61.5.668 · Cited by 10
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608
Ng, A., Tam, W. W., Zhang, M. W., Ho, C. S., Husain, S. F., McIntyre, R. S., & Ho, R. C. (2018) · Scientific Reports · doi:10.1038/s41598-018-30487-6 · Cited by 572
Brosseron, F., Krauthausen, M., Kummer, M., & Heneka, M. T. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8657-1 · Cited by 447
Metadata
- Authors
- Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., & Janka, Z.
- Venue
- Acta Neurologica Scandinavica
- Publisher
- Hindawi Limited
- Published
- 2009-01-29
- Volume
- 96
- Issue
- 4
- Pages
- 236-240
- ISSN
- 0001-6314 (ISSN-L)
- 1600-0404
- OpenAlex
- W2106182781
- Cited by
- 167
- References
- 9
- FWCI
- 4.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 2406 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. https://app.cochat.ai/papers/10.1111/j.1600-0404.1997.tb00275.x
- The paper
- Kálmán, J., Juhász, A., Laird, G., Dickens, P., Járdánházy, T., Rimanóczy, A., Boncz, I., Parry-Jones, W. L. I., & Janka, Z. (2009). Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1997.tb00275.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.